Axon Capital LP’s Ptc Therapeutics Inc Position
Does Axon Capital LP own Ptc Therapeutics Inc (PTCT)? Not currently — the last reported position was 199.1K shares worth $7M in Q3 2019; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$7M
Q3 2019
Shares
199.1K
% of Portfolio
+17.97%
Quarters Held
3
position exited
Position History PTCT
Reported value by quarter
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Axon Capital LP’s full portfolio or all institutional holders of PTCT.